FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1490704389> ?p ?o ?g. }

• W1490704389 endingPage "1748" @default.
• W1490704389 startingPage "1739" @default.
• W1490704389 abstract "Stroke risk is heightened among patients who have had a primary stroke or transient ischaemic attack (TIA). The primary care physician is in the best position to monitor these patients for stroke recurrence. Because stroke recurrence can occur shortly after the primary event, guidelines recommend initiating antiplatelet therapy as soon as possible. Aspirin, with or without extended-release dipyridamole (ER-DP), and clopidogrel are options for such patients. Low-dose aspirin (75-150 mg/day) has the same efficacy as higher doses but with less gastrointestinal bleeding. Clopidogrel remains an option for prevention of secondary events and may benefit patients with symptomatic atherothrombosis, but its combined use with aspirin can harm patients with multiple risk factors and no history of symptomatic cerebrovascular, cardiovascular or peripheral vascular disease.Low dose aspirin is effective in secondary stroke prevention. Trials assessing aspirin plus ER-DP have shown that the combination is more effective than aspirin monotherapy in preventing stroke, with efficacy increasing among higher risk patients, notably those with prior stroke/TIA. Clopidogrel does not appear to have as much advantage over aspirin in secondary stroke prevention as aspirin plus ER-DP. Smoking cessation and cholesterol, blood glucose and blood pressure control are also important concerns in preventing recurrent stroke. In choosing pharmacological therapy, the physician must consider the individual patient's risk factors and tolerance, as well as other issues, such as use of aspirin among patients with ulcers.Antiplatelet therapy is effective in secondary stroke prevention. Low dose aspirin can be used first-line, but aspirin plus ER-DP improves efficacy. Clopidogrel is another option in secondary stroke prevention, especially for aspirin-intolerant patients, but it appears to have less advantage over aspirin than aspirin plus ER-DP, and its combined use with aspirin has only marginally better efficacy and increased bleeding risk." @default.
• W1490704389 created "2016-06-24" @default.
• W1490704389 creator A5018338106 @default.
• W1490704389 date "2007-09-14" @default.
• W1490704389 modified "2023-09-25" @default.
• W1490704389 title "Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician role" @default.
• W1490704389 cites W1498265361 @default.
• W1490704389 cites W1522694313 @default.
• W1490704389 cites W1967906917 @default.
• W1490704389 cites W1987341486 @default.
• W1490704389 cites W1987826243 @default.
• W1490704389 cites W1989935089 @default.
• W1490704389 cites W1991655882 @default.
• W1490704389 cites W1993323415 @default.
• W1490704389 cites W1996134888 @default.
• W1490704389 cites W2024237851 @default.
• W1490704389 cites W2024352468 @default.
• W1490704389 cites W2027538725 @default.
• W1490704389 cites W2039560134 @default.
• W1490704389 cites W2053565388 @default.
• W1490704389 cites W2066167447 @default.
• W1490704389 cites W2077751490 @default.
• W1490704389 cites W2090665964 @default.
• W1490704389 cites W2090899812 @default.
• W1490704389 cites W2099395511 @default.
• W1490704389 cites W2100209149 @default.
• W1490704389 cites W2102463819 @default.
• W1490704389 cites W2111089169 @default.
• W1490704389 cites W2114139836 @default.
• W1490704389 cites W2120531185 @default.
• W1490704389 cites W2120544643 @default.
• W1490704389 cites W2133784818 @default.
• W1490704389 cites W2134004558 @default.
• W1490704389 cites W2135293213 @default.
• W1490704389 cites W2137797595 @default.
• W1490704389 cites W2143004627 @default.
• W1490704389 cites W2148132508 @default.
• W1490704389 cites W2159193915 @default.
• W1490704389 cites W2161254333 @default.
• W1490704389 cites W2165733251 @default.
• W1490704389 cites W2167067204 @default.
• W1490704389 cites W2167806412 @default.
• W1490704389 cites W2169847035 @default.
• W1490704389 cites W2318352361 @default.
• W1490704389 cites W2564261990 @default.
• W1490704389 cites W311320695 @default.
• W1490704389 cites W2030189178 @default.
• W1490704389 cites W2135478774 @default.
• W1490704389 doi "https://doi.org/10.1111/j.1742-1241.2007.01515.x" @default.
• W1490704389 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17877660" @default.
• W1490704389 hasPublicationYear "2007" @default.
• W1490704389 type Work @default.
• W1490704389 sameAs 1490704389 @default.
• W1490704389 citedByCount "15" @default.
• W1490704389 countsByYear W14907043892012 @default.
• W1490704389 countsByYear W14907043892013 @default.
• W1490704389 countsByYear W14907043892015 @default.
• W1490704389 countsByYear W14907043892017 @default.
• W1490704389 countsByYear W14907043892018 @default.
• W1490704389 countsByYear W14907043892019 @default.
• W1490704389 countsByYear W14907043892020 @default.
• W1490704389 countsByYear W14907043892021 @default.
• W1490704389 countsByYear W14907043892022 @default.
• W1490704389 crossrefType "journal-article" @default.
• W1490704389 hasAuthorship W1490704389A5018338106 @default.
• W1490704389 hasBestOaLocation W14907043891 @default.
• W1490704389 hasConcept C126322002 @default.
• W1490704389 hasConcept C127413603 @default.
• W1490704389 hasConcept C164705383 @default.
• W1490704389 hasConcept C177713679 @default.
• W1490704389 hasConcept C2776890861 @default.
• W1490704389 hasConcept C2777628954 @default.
• W1490704389 hasConcept C2777849778 @default.
• W1490704389 hasConcept C2780645631 @default.
• W1490704389 hasConcept C71924100 @default.
• W1490704389 hasConcept C78519656 @default.
• W1490704389 hasConceptScore W1490704389C126322002 @default.
• W1490704389 hasConceptScore W1490704389C127413603 @default.
• W1490704389 hasConceptScore W1490704389C164705383 @default.
• W1490704389 hasConceptScore W1490704389C177713679 @default.
• W1490704389 hasConceptScore W1490704389C2776890861 @default.
• W1490704389 hasConceptScore W1490704389C2777628954 @default.
• W1490704389 hasConceptScore W1490704389C2777849778 @default.
• W1490704389 hasConceptScore W1490704389C2780645631 @default.
• W1490704389 hasConceptScore W1490704389C71924100 @default.
• W1490704389 hasConceptScore W1490704389C78519656 @default.
• W1490704389 hasIssue "10" @default.
• W1490704389 hasLocation W14907043891 @default.
• W1490704389 hasLocation W14907043892 @default.
• W1490704389 hasOpenAccess W1490704389 @default.
• W1490704389 hasPrimaryLocation W14907043891 @default.
• W1490704389 hasRelatedWork W2047171142 @default.
• W1490704389 hasRelatedWork W2074593749 @default.
• W1490704389 hasRelatedWork W2098366884 @default.
• W1490704389 hasRelatedWork W2099734408 @default.
• W1490704389 hasRelatedWork W2133147248 @default.
• W1490704389 hasRelatedWork W2134796367 @default.
• W1490704389 hasRelatedWork W2134860136 @default.

• next